299 related articles for article (PubMed ID: 24361268)
41. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol.
Fang JY; Hwang TL; Huang YL; Fang CL
Int J Pharm; 2006 Mar; 310(1-2):131-8. PubMed ID: 16413711
[TBL] [Abstract][Full Text] [Related]
42. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
[TBL] [Abstract][Full Text] [Related]
43. Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique--a tool for controlled transdermal delivery of ibuprofen.
Abioye AO; Issah S; Kola-Mustapha AT
Int J Pharm; 2015 Jul; 490(1-2):112-30. PubMed ID: 25997660
[TBL] [Abstract][Full Text] [Related]
44. Ibuprofen penetration enhance by sucrose ester examined by ATR-FTIR in vivo.
Csizmazia E; Eros G; Berkesi O; Berkó S; Szabó-Révész P; Csányi E
Pharm Dev Technol; 2012; 17(1):125-8. PubMed ID: 20715904
[TBL] [Abstract][Full Text] [Related]
45. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.
Liu D; Ge Y; Tang Y; Yuan Y; Zhang Q; Li R; Xu Q
J Microencapsul; 2010; 27(8):726-34. PubMed ID: 21034365
[TBL] [Abstract][Full Text] [Related]
46. The comparability of in vitro and ex vivo studies on the percutaneous permeation of topical formulations containing Ibuprofen.
Stahl J; Blume B; Bienas S; Kietzmann M
Altern Lab Anim; 2012 May; 40(2):91-8. PubMed ID: 22762193
[TBL] [Abstract][Full Text] [Related]
47. [Comparative in vitro and in vivo studies on the permeation and penetration of ketoprofen and ibuprofen in human skin].
Bock U; Krause W; Otto J; Haltner E
Arzneimittelforschung; 2004; 54(9):522-9. PubMed ID: 15500198
[TBL] [Abstract][Full Text] [Related]
48. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
[TBL] [Abstract][Full Text] [Related]
49. Influence of physicochemical properties on the in vitro skin permeation of the enantiomers, racemate, and eutectics of ibuprofen for enhanced transdermal drug delivery.
Yuan X; Capomacchia AC
J Pharm Sci; 2013 Jun; 102(6):1957-1969. PubMed ID: 23589422
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
51. Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin.
Mura P; Bragagni M; Mennini N; Cirri M; Maestrelli F
Int J Pharm; 2014 Nov; 475(1-2):306-14. PubMed ID: 25194352
[TBL] [Abstract][Full Text] [Related]
52. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
Chen L; Tan F; Wang J; Liu F
Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
[TBL] [Abstract][Full Text] [Related]
53. [Comparison of the effect of eight kinds of volatile oil of Chinese material medica on percutaneous absorption of ibuprofen in vitro].
Luo XQ; Gu YH; Wu ZY
Zhong Yao Cai; 2007 May; 30(5):571-3. PubMed ID: 17727065
[TBL] [Abstract][Full Text] [Related]
54. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery.
Consola S; Blanzat M; Perez E; Garrigues JC; Bordat P; Rico-Lattes I
Chemistry; 2007; 13(11):3039-47. PubMed ID: 17285653
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.
Caddeo C; Sales OD; Valenti D; Saurí AR; Fadda AM; Manconi M
Int J Pharm; 2013 Feb; 443(1-2):128-36. PubMed ID: 23299087
[TBL] [Abstract][Full Text] [Related]
56. Formulation and delivery strategies of ibuprofen: challenges and opportunities.
Irvine J; Afrose A; Islam N
Drug Dev Ind Pharm; 2018 Feb; 44(2):173-183. PubMed ID: 29022772
[TBL] [Abstract][Full Text] [Related]
57. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
58. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
[TBL] [Abstract][Full Text] [Related]
59. Elastic liposomes mediated transdermal delivery of an anti-jet lag agent: preparation, characterization and in vitro human skin transport study.
Dubey V; Mishra D; Nahar M; Jain NK
Curr Drug Deliv; 2008 Jul; 5(3):199-206. PubMed ID: 18673263
[TBL] [Abstract][Full Text] [Related]
60. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen.
Park ES; Chang SY; Hahn M; Chi SC
Int J Pharm; 2000 Nov; 209(1-2):109-19. PubMed ID: 11084251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
